New painkiller exparel tested for hernia surgery recovery
NCT ID NCT02128646
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a long-acting painkiller called Exparel (liposomal bupivacaine) can control pain better after open or laparoscopic hernia repair. Nineteen adults having hernia surgery received Exparel along with standard care. Researchers measured patient satisfaction with pain control and time spent in recovery. The goal is to find a way to manage post-surgery pain with fewer opioids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Exparel (liposomal bupivacaine)
- What this could lead to
- If it works, this could offer better pain control after hernia surgery, reducing the need for opioids.
- What could go wrong
- This is a small, completed Phase 4 study with only 19 participants, so results may not apply to everyone. Pain management varies widely between individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?